dihexa chemical properties solubility stability formulation (PNB-0408) | c-Met/HGFR Activator DIHEXA | Peptide Synthetic |
DIHEXA Peptide Synthetic High Purity ProSpec A method that enables rapid access to glutarimides has been reported in a collaboration between the Baran Lab and BMS. Glutarimides are a key motif in the TPD (targeted protein degradation) field As part of its strategy to explore additional delivery systems for MEAI, Clearmind initiated formulation feasibility studies to evaluate the compound's suitability for intranasal administration. Initial work focused on evaluating MEAI's compatibility with Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs) Pharmaceutical Outsourcing The Journal of Pharmaceutical & Biopharmaceutical Contract Services Dihexa 1401708 83 5 BGC70883 Biosynth
Pay in 4 interest-free payments of $5.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1


